Nosocomial infections in chronic critical illness – risk assessment, personalized diagnostics and treatment

UDC: 
616.94
Authors: 

G.G. Onishchenko, А.V. Grechko, А.N. Kuzovlev

Organization: 

Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 25 Petrovka Str., build. 2, Moscow, 107031, Russian Federation

Abstract: 

The developmental trajectory of critical illness varies and is largely determined by genetic and immunological charac-teristics. This determines significant heterogeneity of critically ill patients and necessitates fundamental research in this area to develop algorithms for personalized diagnosis, treatment, and outcome prediction.

The aim of this study was to analyze the results of basic research conducted by the Federal Research and Clinical Center of Intensive Care Medicine on assessing the risk of nosocomial infections, their personalizing diagnosis, and treating in patients with chronic critical illness.

A review of the scientific literature from leading international and Russian databases was conducted. Databases used: PubMed/MEDLINE, Scopus, and eLibrary. Search period: 2015–2026. The RICD database developed by the Federal Research and Clinical Center of Intensive Care Medicine was used for data analysis.

Further development of intensive care medicine is impossible without a fundamental study of heterogeneity of patients in critical conditions. In this work, we analyzed scientific publications devoted to the concept of chronic critical illness, the etiological structure of pathogens of nosocomial respiratory tract infections in patients in chronic critical illness, genetic and immunological markers of the course and expected outcomes of critical conditions in various categories of patients, technology of personalized phage prophylaxis and phage therapy of nosocomial infections in patients in chronic critical illness. Our research work forms the basis for developing and implementing innovative algorithms for personalized diagnosis and treatment of nosocomial infections in critical conditions in clinical practice. These algorithms are based on understanding of the pathogenesis, genetic and immunological heterogeneity of chronic critical illness, personalized application of treatment and rehabilitation methods.

Keywords: 
personalization, intensive care medicine, critical condition, nosocomial infection, biomarker, genetics, immunology, phage prophylaxis, phage therapy
Onishchenko G.G., Grechko А.V., Kuzovlev А.N. Nosocomial infections in chronic critical illness – risk assessment, per-sonalized diagnostics and treatment. Health Risk Analysis, 2026, no. 2, pp. 97–106. DOI: 10.21668/health.risk/2026.2.09.eng
References: 
  1. Ershov V.I., Gritsan A.I., Belkin A.A., Zaboiotskikh I.B., Gorbachev V.I., Lebedinskii K.M., Leyderman I.N., Petrikov S.S. [et al.]. Russian multiple-center observational clinical study “Register of respiratory therapy for patients with stroke (RETAS)”: aspects of mechanical ventilation. Anesteziologiya i reanimatologiya, 2021, no. 6, pp. 25–34. DOI: 10.17116/anaesthesiology202106125 (in Russian).
  2. Likhvantsev V.V., Berikashvili L.B., Yadgarov M.Ya., Yakovlev A.A., Kuzovlev A.N. The Tri-Steps Model of Critical Conditions in Intensive Care: Introducing a New Paradigm for Chronic Critical Illness. J. Clin. Med., 2024, vol. 13, no. 13, pp. 3683. DOI: 10.3390/jcm13133683
  3. Polcz V.E., Barrios E.L., Larson S.D., Efron P.A., Rincon J.C. Charting the course for improved outcomes in chronic critical illness: therapeutic strategies for persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Br. J. Anaesth., 2024, vol. 133, no. 2, pp. 260–263. DOI: 10.1016/j.bja.2024.05.005
  4. Zebian G., Kreitmann L., Houard M., Piantoni A., Piga G., Ruffier des Aimes S., Holik B., Wallet F. [et al.]. Immu-nosuppression at ICU admission is not associated with a higher incidence of ICU-acquired bacterial bloodstream infections: the COCONUT study. Ann. Intensive Care, 2024, vol. 14, no. 1, pp. 83. DOI: 10.1186/s13613-024-01314-1
  5. Kameneva T.R., Bazanovich S.A., Yuryev M.Y., Zhdanova M.A., Golubeva M.A., Luginina E.V., Petrova M.V. Etio-logical Structure of Lower Respiratory Tract Pathogens in Treatment and Rehabilitation of Patients with Chronic Critical Illness in Intensive Care Units. Fizicheskaya i reabilitatsionnaya meditsina, meditsinskaya reabilitatsiya, 2025, vol. 7, no. 2,
    pp. 95–108. DOI: 10.36425/rehab681966 (in Russian).
  6. Kriticheskie sostoyaniya pri koronavirusnoi infektsii COVID-19: patogeneticheskie, klinicheskie i prognosticheskie aspekty [Critical Conditions in Coronavirus Infection COVID-19: Pathogenetic, Clinical and Prognostic Aspects]. Moscow, Advanced Solutions LLC, 2025, 260 p. (in Russian).
  7. Consalvo F., Padovano M., Scopetti M., Morena D., Cipolloni L., Fineschi V., Santurro A. Analysis of miRNA Ex-pression Profiles in Traumatic Brain Injury (TBI) and Their Correlation with Survival and Severity of Injury. Int. J. Mol. Sci., 2024, vol. 25, no. 17, pp. 9539. DOI: 10.3390/ijms25179539
  8. Merritt V.C., Maihofer A.X., Gasperi M., Chanfreau-Coffinier C., Stein M.B., Panizzon M.S., Hauger R.L., Logue M.W. [et al.]. Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA Million Veteran Program. Mol. Psychiatry, 2024, vol. 29, no. 1, pp. 97–111. DOI: 10.1038/s41380-023-02304-8
  9. Fetlam D.L., Chumachenko A.G., Ilyichev A.V., Pisarev V.M. Polymorphism of OLR1 Gene Encoding Oxidized LDL Receptor LOX-1 Modifies the Course of Necrotizing Pulmonary Infection. General Reanimatology, 2026, vol. 22, no. 1, pp. 14–25. DOI: 10.15360/1813-9779-2026-1-2617
  10. Pisarev V.M., Chumachenko A.G., Fetlam D.L., Kuzovlev A.N. Host AQP4 genetic polymorphism and Gram-negative bacteria Predict septic shock and outcome in pleural empyema patients. Shock, 2025, vol. 64, no. S3, pp. S24. DOI: 10.1097/SHK.0000000000002663
  11. Chumachenko A.G., Vyazmina M.D., Kalov A.R., Petrova M.V., Pisarev V.M. Contribution of AGTR1 rs275651 ge-netic polymorphism and immune system cells to survival of patients after haemorrhagic stroke: a prospective cohort study. Annals of Critical Care, 2026, no. 2, pp. 56–74. DOI: 10.21320/1818-474X-2026-2-56-74 (in Russian).
  12. Pisarev V.M., Chumachenko A.G., Kalov A.R., Ilyichev A.V., Zakharchenko V.E., Petrova M.V. Informativeness of Immunological Predictors of Prolonged and Chronic Critical Illness Outcome is Limited by Patient’s Genotype. General Reani-matology, 2025, vol. 21, no. 6, pp. 22–34. DOI: 10.15360/1813-9779-2025-6-2599
  13. Grebenchikov O.A., Kasatkina I.S., Kadantseva K.K., Meshkov M.A., Bayeva A.A. The Effect of Lithium Chloride on Neutrophil Activation on Exposure to Serum of Patients with Septic Shock. General Reanimatology, 2020, vol. 16, no. 5, pp. 45–55. DOI: 10.15360/1813-9779-2020-5-45-55
  14. Dementev I.M., Gabitov M.V., Timoshin S.S., Kuzovlev A.N., Grebenchikov O.A. Early administration of xenon-oxygen mixture in neonatal hypoxic-ischemic encephalopathy. Bulletin of RSMU, 2026, no. 2, pp. 55–60. DOI: 10.24075/brsmu.2026.009
  15. Green S.I., Clark J.R., Santos H.H., Weesner K.E., Salazar K.C., Aslam S., Campbell J.W., Doernberg S.B. [et al.].
    A retrospective, observational study of 12 cases of expanded-access customized phage therapy: production, characteristics, and clinical outcomes. Clin. Infect. Dis., 2023, vol. 77, no. 8, pp. 1079–1091. DOI: 10.1093/cid/ciad335
  16. Vaezi A., Healy T., Ebrahimi G., Rezvankhah S., Hashemi Shahraki A., Mirsaeidi M. Phage therapy: breathing new tactics into lower respiratory tract infection treatments. Eur. Respir. Rev., 2024, vol. 33, no. 172, pp. 240029. DOI: 10.1183/16000617.0029-2024
  17. Legostaeva L.A., Suponeva N.A., Sergeev D.V., Iazeva E.G., Ryabinkina Yu.V., Gnedovskaya E.V., Belkin A.A., Pe-trova M.V. [et al.]. Challenges in providing care to patients with disorders of consciousness in Russia: an online survey of healthcare professionals. Annals of Critical Care, 2026, no. 1, pp. 86–97. DOI: 10.21320/1818-474X-2026-1-86-97
  18. Mayorova L.A., Grechko A.V., Fateeva V.V. A two-year prospective longitudinal study of the dynamics of cognitive functions in different periods of stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski, 2023, vol. 123, no. 12–2, pp. 36–42. DOI: 10.17116/jnevro202312312236 (in Russian).
  19. Berikashvili L.B., Shestopalov A.E., Polyakov P.A., Yakovleva A.V., Yadgarov M.Y., Kuznetsov I.V., Said M.T.S.M., Sergeev I.V. [et al.]. The Neurological Metabolic Phenotype in Prolonged/Chronic Critical Illness: Propensity Score Matched Analysis of Nutrition and Outcomes. Nutrients, 2025, vol. 17, no. 14, pp. 2302. DOI: 10.3390/nu17142302
Received: 
15.05.2026
Approved: 
04.06.2026
Accepted for publication: 
27.06.2026

You are here